Puyin International: downgraded BeiGene A-share rating to 'hold', maintaining target price of 181 yuan
因醉鞭名马幌
发表于 昨天 16:33
124
0
0
Caixin News Agency, November 14th - Puyin International released a research report, maintaining the "buy" rating of BeiGene (688235) on US and Hong Kong stocks, and adjusting the target prices of US and Hong Kong stocks to 255 US dollars and 153 Hong Kong dollars; Downgrading the A-share rating to 'hold' and maintaining the A-share target price of RMB 181.
In the third quarter of 2024, the company's performance was slightly lower than expected, but it achieved adjusted Non GAAP operating profit better than expected for two consecutive quarters: the total revenue of the company in the third quarter reached 1.002 billion US dollars (year-on-year+28.2%, month on month+7.8%), and the net loss was 121 million US dollars (year-on-year -156.3%, month on month+0.8%), which is basically in line with Visible Alpha expectations and lower than Puyin International's expectations, mainly due to slightly lower than expected gross profit margin and slightly higher than expected R&D expenses.
Zebutinib sales in the United States slowed down in the third quarter compared to the previous quarter, mainly due to seasonal factors and the impact of one-time drug purchases at the end of the second quarter, while sales in Europe continued to grow strongly.
The gross profit margin was temporarily affected by the depreciation of new production lines, and the sales management expense ratio further decreased. The R&D expense ratio in the third quarter was 496 million US dollars (year-on-year+9.5%, month on month+9.2%), with a slight increase compared to the second quarter, mainly due to continuous investment in R&D projects; The sales management expenses were $455 million, with an expense ratio of 45.4%, slightly lower than the second quarter (47.8%), reflecting higher operational efficiency. In the future, with the further expansion of revenue scale, we expect that there is still room for further decline in the sales management expense ratio.
In addition, BeiGene's research and development is progressing smoothly, and the next step of the pipeline will focus on BCL2, BTKCDAC, and CDK4 inhibitors.
In the end, Puyin International maintained BeiGene's "buy" rating on the US and Hong Kong stocks, and adjusted the target prices for the US and Hong Kong stocks to $255 and HKD 153; Downgrading the A-share rating to 'hold' and maintaining the A-share target price of 181 yuan.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Bank of America Global Research will raise Goldman Sachs' target price from $563 to $575
- Paijie Investment lowers Microsoft's target price from $485 to $470 to maintain its overweight rating
- BeiGene executive Yin Min is under investigation after previously serving at AstraZeneca | News
- A senior executive of BeiGene has been investigated, and insiders say that the reason for the investigation is unrelated to BeiGene
- BeiGene executive Yin Min is suspected of smuggling and cooperating with the investigation
- Barclays raises Tesla target price from $220 to $235
- Morgan Stanley: Lowering AMD target price from $178 to $169
- Morgan Stanley: Lowering AMD target price from $178 to $169
- Barclays raises Chevron's target price from $168 to $174
- Huili Securities downgraded Tesla rating to selling target price of $230
-
南方財経は11月12日、百済神州が2024年第3四半期の報告書を発表し、同社の第3四半期の営業収入は71.39億元で、前年同期比26.9%増加した。上場企業の株主に帰属する純利益は-8.09億元で、主に前年同期に百時米施貴宝 ...
- 1900_后
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
北京商報(何倩記者)は11月14日、「チャトンと野菜を買ってサウジに出航した」との情報に対し、チャトンと野菜を買った関係責任者は北京商報記者に対し、関連業務はまだ初歩的な模索にすぎず、しばらく詳細な情報 ...
- 柔柔树呆熊呆j
- 昨天 16:39
- 支持
- 反对
- 回复
- 收藏
-
黄仁勲が最新発表! 11月13日、英偉達の黄仁勲CEOは英偉達日本サミットで、日本最大のAI工場を含むソフトバンクと協力して日本にAIインフラを構築すると発表した。ソフトバンクの孫正義元会長兼社長は、「ソフトバ ...
- tomy123123
- 前天 14:57
- 支持
- 反对
- 回复
- 收藏
-
【世界市場】1、ダウは0.11%、スタンダードは0.02%、ナノ指は0.26%下落した。2、大型科学技術株の多くが上昇し、アマゾンは2%超上昇し、株価は過去最高を記録した。3、国際金価格は4日連続で下落し、2600ドルの関門 ...
- 就放荡不羁就h
- 昨天 14:54
- 支持
- 反对
- 回复
- 收藏